ultrainnovative – Tackle rare and dynamic challenges
This key position will represent Global Health Economics and Outcomes Research (HEOR) across functional teams for pipeline and commercialized programs.
The Senior Director Global HEOR, is responsible for leading the development and tactical execution of HEOR strategies for pipeline and commercialized programs, working cross-functionally to provide leadership for HEOR across the portfolio of Ultragenyx programs globally.
Generate HEOR data to support clinical development and reimbursement filings, including design, implementation and data analysis of HEOR studies and provide consultation as an internal subject matter authority in HEOR to other departments.
Research activities can include cost-effectiveness models, budget impact analyses, systematic literature reviews and indirect comparisons, cost-of-illness and burden of illness studies, retrospective data analyses and claims analyses, data analytics and publications.
This global role will lead HEOR assessments using existing bodies of evidence and generating data where they do not exist and will assist with any relevant HEOR and outcomes research, statistical analysis plans, and analysis output as requested across programs.
Work Model:Remote: Officially documented as working full-time from home, with travel to Ultragenyx's offices or other locations on occasion as needed.
Responsibilities:- Identified as an HEOR subject matter expert, able to provide consultation as an internal HEOR subject matter authority to other departments and responsible for developing HEOR strategy and leadership among cross-functional project teams, to mitigate risk and achieve success, across the portfolio of Ultragenyx programs globally
- Generate HEOR data to support clinical development and reimbursement, including design, implementation and analysis of HEOR studies
- Proactively collaborates and demonstrates cross-functional leadership across the organization to facilitate alignment around key HEOR endpoints, outcomes and deliverables and partners closely with internal stakeholders, including medical, clinical development, commercial, market access, endpoint development strategy and management team to identify and develop appropriate HEOR strategy to support global development and reimbursement plans across US, Canada, EMEA, LATAM and APAC regions
- Identify evidence gaps to inform strategic planning and lead development of new evidence strategies to increase understanding of target patient populations of UGX programs and lead development of new evidence generation strategies to achieve market access across global target patient populations of UGX programs
- Review and provide health economics and outcomes research input into clinical development program planning, integrated evidence generation plans, regulatory documents with accuracy and scientific integrity
- Provide leadership through influencing without authority across project teams, internally and externally, can identify & lead cross functional teams for external collaborative research partnerships from project inception thru publication(s) and presentation(s)
- Represent Ultragenyx as Global HEOR subject matter expert at external professional, scientific meetings and forums
- BA/BS in the Life Sciences, Public Health, Epidemiology or Health Economics and MA/MS in the Life Sciences, Public Health, Epidemiology, Health Economics or Pharmacy; Prefer advanced degree in the life sciences (PharmD, PhD, MD)
- 12 + years of relevant experience in biopharmaceutical industry, with health economics and outcomes research, with clinical background/research experience preferred
- Excellent interpersonal and organizational skills with the ability to work well in a multidisciplinary team and across the matrix. Key stakeholders include Medical Strategy, Clinical Development, Regional Market Access, Biostatistics, Molecular Diagnostics, Epidemiology, Global and Regional Commercial
- Experience in health economics and outcomes research activities including de novo evidence generation, economic modelling, input into clinical trial design & analysis, evidence- based synthesis from literature, and study design, data management and analysis.
- Effective communication of HEOR strategy and findings, both written and verbal, is required.
- Self-motivated with the ability to work independently, across multiple assets, and to develop credibility with colleagues, influence decisions with excellent interpersonal and organizational skills with the ability to work well in a multidisciplinary team and across the matrix.
- Strong technical expertise in HEOR principles, and knowledge of analytical applications, demonstrating a sophisticated understanding of, and the ability to interpret, quantitative methods is required
- Experience in strategic planning and project management, with proficiency in working cross-cultural/global teams
- Experience in Gene Therapy and in Global HEOR strongly preferred
- Experience in Rare Disease preferred
- Travel: approximate 10-25%
#LI-CS1 #LI-Remote
The typical annual salary range for this full-time position is listed below. This range reflects the characteristics of the job, such as required skills and qualifications and is based on the office location noted in this job posting. The range may also be adjusted based on applicant's geographic location.
This position is eligible for annual bonus and equity incentives. Actual individual pay is determined by demonstrated experience and internal equity alignment.
Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law, including individuals with disabilities, disabled veterans, for pregnancy, childbirth, and related medical conditions, and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing us at [email protected].
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
Skills Required
- 12+ years of relevant experience in biopharmaceutical industry
- BA/BS and MA/MS in relevant life sciences
- Experience in health economics and outcomes research
- Strong technical expertise in HEOR principles
- Experience in Gene Therapy and Global HEOR preferred
- Experience in Rare Disease preferred
Ultragenyx Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Ultragenyx and has not been reviewed or approved by Ultragenyx.
-
Healthcare Strength — Benefits begin on the first day with multiple medical plan options alongside dental and vision coverage. Employer-funded HSA contributions and employer-paid mental health support via Spring Health add notable depth to healthcare support.
-
Leave & Time Off Breadth — Paid time off is broadened by two fully paid company shutdown weeks in August and December in addition to holidays and baseline vacation. Paid sick time, paid volunteer time, and a substantial paid leave program further expand time-off support.
-
Retirement Support — Retirement support includes a 401(k) program with a match on employee contributions and immediate vesting. An employee stock purchase plan discount also strengthens the overall financial rewards package.
Ultragenyx Insights
What We Do
At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them.
.jpg)
